SCHEMBL21485490

SCHEMBL21485490

c1ccc(-c2cccc(-n3c4ccccc4c4cc(-c5ccc(-c6ccc7c(c6)c6ccccc6n7-c6ccc7c(c6)oc6ccccc67)cc5)ccc43)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 3/20 0.41
KDM4E B2RXH2 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PLA2G2A P14555 4/20 0.39
PLA2G4A P47712 4/20 0.39
PTGER4 P35408 1/20 0.37
AHR P35869 2/20 0.37
PLA2G10 O15496 1/20 0.37
MMP12 P39900 1/20 0.37
MMP13 P45452 1/20 0.37
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 2/20 0.36
TSPO P30536 1/20 0.36
HPGD P15428 1/20 0.36
EDNRB P24530 1/20 0.34
EDNRA P25101 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15964300 1.00 ATM (0.41) ATMKDM4EL3MBTL1PLA2G2APLA2G4A
SCHEMBL25941257 1.00 ATM (0.41) ATMKDM4EL3MBTL1PLA2G2APLA2G4A
SCHEMBL22174964 0.99 ATM (0.41) ATMKDM4EL3MBTL1PLA2G2APLA2G4A
SCHEMBL19009381 0.98 ATM (0.40) ATMKDM4EL3MBTL1PLA2G2APLA2G4A
SCHEMBL19009388 0.98 ATM (0.40) ATMKDM4EL3MBTL1PLA2G2APLA2G4A
SCHEMBL25941123 0.98 ATM (0.40) ATMKDM4EL3MBTL1PLA2G2APLA2G4A
SCHEMBL22174958 0.98 ATM (0.40) ATMKDM4EL3MBTL1PLA2G2APLA2G4A
SCHEMBL12088585 0.98 ATM (0.40) ATMKDM4EL3MBTL1PLA2G2APLA2G4A
SCHEMBL17248340 0.97 KDM4E (0.40) ATMKDM4EL3MBTL1PLA2G2APLA2G4A
SCHEMBL22671689 0.96 ATM (0.44) ATMKDM4EL3MBTL1PLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230363270-A1 ORGANIC COMPOUNDS, ORGANIC MIXTURES AND THE USES THEREOF Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-09 US disclosed
US-20230363270-A1 ORGANIC COMPOUNDS, ORGANIC MIXTURES AND THE USES THEREOF Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-09 US disclosed
US-20190319197-A1 ORGANIC COMPOUND, APPLICATIONS THEREOF, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC DEVICE GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) 2019-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190319197-A1 ORGANIC COMPOUND, APPLICATIONS THEREOF, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC DEVICE PIEZO1, OR10J3, OR51E2 ATM 2334/4885KDM4E 2904/4885L3MBTL1 1968/4885
US-20230363270-A1 ORGANIC COMPOUNDS, ORGANIC MIXTURES AND THE USES THEREOF AOX1, ODC1, OTC ATM 2511/4885KDM4E 4036/4885L3MBTL1 2702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.